Shigenobu Suzuki
- Ophthalmology top 0.5%
- Nephrology top 1%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Co-authors
- Akihiro KanekoSoichiro MiuraYuichi KikuchiToshihiko ImakiireYasuhiko TominoMakoto AraieAiko IwaseMakoto Mohri
- Topics
- Ocular Oncology and Treatments (23 papers)Renal Diseases and Glomerulopathies (14 papers)Chronic Kidney Disease and Diabetes (11 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaKidney International
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Shigenobu Suzuki
79 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 106
- Ophthalmology 751
- Nephrology 499
- Radiology, Nuclear Medicine and Imaging 466
- Pulmonary and Respiratory Medicine 463
- Molecular Biology 413
Countries citing papers authored by Shigenobu Suzuki
This map shows the geographic impact of Shigenobu Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigenobu Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigenobu Suzuki more than expected).
Fields of papers citing papers by Shigenobu Suzuki
This network shows the impact of papers produced by Shigenobu Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigenobu Suzuki. The network helps show where Shigenobu Suzuki may publish in the future.
Co-authorship network of co-authors of Shigenobu Suzuki
This figure shows the co-authorship network connecting the top 25 collaborators of Shigenobu Suzuki. A scholar is included among the top collaborators of Shigenobu Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigenobu Suzuki. Shigenobu Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 5 | |
| 7 | 10 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 7 | |
| 11 | 158 | |
| 12 | 27 | |
| 13 | 8 | |
| 14 | 14 | |
| 15 | 79 | |
| 16 | 12 | |
| 17 | 34 | |
| 18 | 27 | |
| 19 | Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan. | 55 |
| 20 | 15 |
About Shigenobu Suzuki
Shigenobu Suzuki is a scholar working on Ophthalmology, Nephrology and Oncology, having authored 85 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (23 papers), Renal Diseases and Glomerulopathies (14 papers) and Chronic Kidney Disease and Diabetes (11 papers). The work is most often cited by research in Ophthalmology (751 citations), Nephrology (499 citations) and Transplantation (68 citations). Shigenobu Suzuki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Akihiro Kaneko, Soichiro Miura, Yuichi Kikuchi, Toshihiko Imakiire, Yasuhiko Tomino, Makoto Araie, Aiko Iwase, Makoto Mohri, Takashi Yamane and Ryota Ikee. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.